Clinical Trial Update: Pharmacogenetics of Response to Sitagliptin (PRS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining pharmacogenetics of response to sitagliptin in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Diabetes | Phase 4 | Status: NOT_YET_RECRUITING